Ginkgo Bioworks/DNA

$1.29

-15.78%
-
1D1W1MYTD1YMAX

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. It operates through two segments: Cell Engineering and Biosecurity. The Cell Engineering segment consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It offers Concentric, which is a global infrastructure for biosecurity to prevent, detect and respond to a wide variety of biological threats. The Company is also building and deploying machine learning models to solve impactful problems in biology.

Ticker

DNA

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Jason Kelly

Employees

1,292

Headquarters

Boston, United States

Ginkgo Bioworks Metrics

BasicAdvanced
$2.62B
Market cap
-
P/E ratio
-$0.45
EPS
-
Beta
-
Dividend rate

What the Analysts think about Ginkgo Bioworks

Analyst Ratings

Majority rating from 8 analysts.
Hold

Price Targets

Average projection from 6 analysts.
84.5% upside
High $3.40
Low $1.10
$1.29
Current price
$2.38
Average price target

Ginkgo Bioworks Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-546.57% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$55.4M
-31.18%
Net income
$-302.8M
74.73%
Profit margin
-546.57%
153.9%

Ginkgo Bioworks Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 13.79%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.11
-$0.09
-$0.16
-$0.11
-
Expected
-$0.09
-$0.08
-$0.09
-$0.10
-$0.08
Surprise
22.22%
6.78%
86.67%
13.79%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Ginkgo Bioworks stock

Buy or sell Ginkgo Bioworks stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing